The need for treatment of human immunodeficiency virus (HIV 1), arises primarily from the increasing number of infected patients, since they can led to cause acquired immune deficiency syndrome (AIDS). Darunavir (Prezista) is engaged in blocking enzyme called protease which is involved in the reproduction of HIV. In addition, it is given in combination with other antiviral drugs, which reduces the amount HIV in the blood and maintain it at low level. Moreover, it does not cure HIV infection but it may delay the damage to the immune system. 

Darunavir (Prezista) is particularly utilized for the treatment of HIV-1 infection in adult and pediatric patients with 3 years of age and above. In addition, darunavir is available in different range of dosage form i.e. tablet 75 mg to 800 mg, which allows to manage the level of resistance and cross-resistance of combination therapy. Darunavir is not solely administered, it is co-administered with ritonavir and with other antiretroviral agents for better efficacy and results in maintaining the level of HIV-1 in the human blood. Furthermore, before the initiation of prezista certain test are essential includes treatment history, genotypic and phenotypic tests to asses drug susceptibility of the HIV-1 virus. Prezista are expected to grow at a high rate owing to increase in patient number with HIV infection. Darunavir market is expected to grow at a major CAGR due to the ability to growing number of patients with HIV-1 infection especially in low and middle income countries. Moreover, scientific improvements, and increase in number of patients worldwide will also support the darunavir (prezista) market growth. However, hepatotoxicity, severe skin reactions and resistance and cross-resistance are certain challenges which may hamper the market growth of darunavir (prezista). 

The darunavir (prezista) market has been segmented by formulation, by dosage, and by geography. In terms of formulation, the darunavir (prezista) has been categorized into solid dosage formulation and suspension formulation. Hence, darunavir (prezista) in these preparations would play a major role in the treatment of human immunodeficiency virus (HIV 1) in adults and pediatrics above 3 years. Based on dosage, the darunavir (prezista) market has been segmented into oral suspension 100 mg/ml, tablets 75 mg, tablet 150 mg, tablet 600 mg, and tablet 800 mg. 

Geographically, North America was observed to be the largest darunavir (prezista) market due to extensive research and developments in the region. Countries such as the U.S. and Canada have been successful in the use of darunavir (prezista), which as a result would boost the market growth. Moreover, presence of healthcare infrastructure, promising government initiatives in implementing darunavir (prezista) in the HIV-1 infection treatment and constantly improving reimbursement scenario would further propel the darunavir (prezista) market growth. Europe was observed to be the second largest market in the darunavir owing to enhanced healthcare processes and implementation of high healthcare concerns in the region. The major factor that would drive the market in Asia Pacific include the increased number patients infected to HIV in the region. China, Japan and India are the most developing countries in the region and hence would fuel the market growth for darunavir (prezista). South American countries such as Brazil and Mexico are the regions that have significant potential for growth due to evolving medical structure, and high disposable income. 

The major players operating in this darunavir (prezista) market include Janseen Pharmaceuticals, Inc., Inc, Teva Pharmaceuticals, Lupin Pharmaceuticals, Inc., Mylan Pharmaceutical Company, Hetero Healthcare Ltd. among other significant players worldwide.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Darunavir Market

Pre Book